Global Inhaled Nitric Oxide Delivery System Market Growth 2026-2032

October 2026 | 90 pages | ID: IB19EF150A51EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Inhaled Nitric Oxide Delivery System market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Inhaled Nitric Oxide Delivery System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Inhaled Nitric Oxide Delivery System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Inhaled Nitric Oxide Delivery System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Inhaled Nitric Oxide Delivery System players cover Mallinckrodt, Santair AE, VERO Biotech, Linde plc, Beyond Air, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Inhaled Nitric Oxide Delivery System Industry Forecast” looks at past sales and reviews total world Inhaled Nitric Oxide Delivery System sales in 2025, providing a comprehensive analysis by region and market sector of projected Inhaled Nitric Oxide Delivery System sales for 2026 through 2032. With Inhaled Nitric Oxide Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhaled Nitric Oxide Delivery System industry.

This Insight Report provides a comprehensive analysis of the global Inhaled Nitric Oxide Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhaled Nitric Oxide Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhaled Nitric Oxide Delivery System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhaled Nitric Oxide Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhaled Nitric Oxide Delivery System.

This report presents a comprehensive overview, market shares, and growth opportunities of Inhaled Nitric Oxide Delivery System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

  • Pediatric
  • Adult

Segmentation by Application:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Mallinckrodt
  • Santair AE
  • VERO Biotech
  • Linde plc
  • Beyond Air, Inc.
  • SLE
  • Bellerophon Therapeutics
  • Air Liquide Healthcare
  • International Biomedical
  • Circassia Pharmaceuticals

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Inhaled Nitric Oxide Delivery System market?
  • What factors are driving Inhaled Nitric Oxide Delivery System market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Inhaled Nitric Oxide Delivery System market opportunities vary by end market size?
  • How does Inhaled Nitric Oxide Delivery System break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Inhaled Nitric Oxide Delivery System Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Inhaled Nitric Oxide Delivery System by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Inhaled Nitric Oxide Delivery System by Country/Region, 2021, 2025 & 2032
2.2 Inhaled Nitric Oxide Delivery System Segment by Type
  2.2.1 Pediatric
  2.2.2 Adult
  2.2.3 Inhaled Nitric Oxide Delivery System Sales by Type
    2.2.3.1 Global Inhaled Nitric Oxide Delivery System Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Inhaled Nitric Oxide Delivery System Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Inhaled Nitric Oxide Delivery System Sale Price by Type (2021-2026)
2.3 Inhaled Nitric Oxide Delivery System Segment by Application
  2.3.1 Hospitals
  2.3.2 Ambulatory Surgical Centers
  2.3.3 Others
  2.3.4 Inhaled Nitric Oxide Delivery System Sales by Application
    2.3.4.1 Global Inhaled Nitric Oxide Delivery System Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Inhaled Nitric Oxide Delivery System Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Inhaled Nitric Oxide Delivery System Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Inhaled Nitric Oxide Delivery System Breakdown Data by Company
  3.1.1 Global Inhaled Nitric Oxide Delivery System Annual Sales by Company (2021-2026)
  3.1.2 Global Inhaled Nitric Oxide Delivery System Sales Market Share by Company (2021-2026)
3.2 Global Inhaled Nitric Oxide Delivery System Annual Revenue by Company (2021-2026)
  3.2.1 Global Inhaled Nitric Oxide Delivery System Revenue by Company (2021-2026)
  3.2.2 Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Company (2021-2026)
3.3 Global Inhaled Nitric Oxide Delivery System Sale Price by Company
3.4 Key Manufacturers Inhaled Nitric Oxide Delivery System Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Inhaled Nitric Oxide Delivery System Product Location Distribution
  3.4.2 Players Inhaled Nitric Oxide Delivery System Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INHALED NITRIC OXIDE DELIVERY SYSTEM BY GEOGRAPHIC REGION

4.1 World Historic Inhaled Nitric Oxide Delivery System Market Size by Geographic Region (2021-2026)
  4.1.1 Global Inhaled Nitric Oxide Delivery System Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Inhaled Nitric Oxide Delivery System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Inhaled Nitric Oxide Delivery System Market Size by Country/Region (2021-2026)
  4.2.1 Global Inhaled Nitric Oxide Delivery System Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Inhaled Nitric Oxide Delivery System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Inhaled Nitric Oxide Delivery System Sales Growth
4.4 APAC Inhaled Nitric Oxide Delivery System Sales Growth
4.5 Europe Inhaled Nitric Oxide Delivery System Sales Growth
4.6 Middle East & Africa Inhaled Nitric Oxide Delivery System Sales Growth

5 AMERICAS

5.1 Americas Inhaled Nitric Oxide Delivery System Sales by Country
  5.1.1 Americas Inhaled Nitric Oxide Delivery System Sales by Country (2021-2026)
  5.1.2 Americas Inhaled Nitric Oxide Delivery System Revenue by Country (2021-2026)
5.2 Americas Inhaled Nitric Oxide Delivery System Sales by Type (2021-2026)
5.3 Americas Inhaled Nitric Oxide Delivery System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Inhaled Nitric Oxide Delivery System Sales by Region
  6.1.1 APAC Inhaled Nitric Oxide Delivery System Sales by Region (2021-2026)
  6.1.2 APAC Inhaled Nitric Oxide Delivery System Revenue by Region (2021-2026)
6.2 APAC Inhaled Nitric Oxide Delivery System Sales by Type (2021-2026)
6.3 APAC Inhaled Nitric Oxide Delivery System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Inhaled Nitric Oxide Delivery System by Country
  7.1.1 Europe Inhaled Nitric Oxide Delivery System Sales by Country (2021-2026)
  7.1.2 Europe Inhaled Nitric Oxide Delivery System Revenue by Country (2021-2026)
7.2 Europe Inhaled Nitric Oxide Delivery System Sales by Type (2021-2026)
7.3 Europe Inhaled Nitric Oxide Delivery System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Inhaled Nitric Oxide Delivery System by Country
  8.1.1 Middle East & Africa Inhaled Nitric Oxide Delivery System Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Inhaled Nitric Oxide Delivery System Revenue by Country (2021-2026)
8.2 Middle East & Africa Inhaled Nitric Oxide Delivery System Sales by Type (2021-2026)
8.3 Middle East & Africa Inhaled Nitric Oxide Delivery System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhaled Nitric Oxide Delivery System
10.3 Manufacturing Process Analysis of Inhaled Nitric Oxide Delivery System
10.4 Industry Chain Structure of Inhaled Nitric Oxide Delivery System

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Inhaled Nitric Oxide Delivery System Distributors
11.3 Inhaled Nitric Oxide Delivery System Customer

12 WORLD FORECAST REVIEW FOR INHALED NITRIC OXIDE DELIVERY SYSTEM BY GEOGRAPHIC REGION

12.1 Global Inhaled Nitric Oxide Delivery System Market Size Forecast by Region
  12.1.1 Global Inhaled Nitric Oxide Delivery System Forecast by Region (2027-2032)
  12.1.2 Global Inhaled Nitric Oxide Delivery System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Inhaled Nitric Oxide Delivery System Forecast by Type (2027-2032)
12.7 Global Inhaled Nitric Oxide Delivery System Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Mallinckrodt
  13.1.1 Mallinckrodt Company Information
  13.1.2 Mallinckrodt Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.1.3 Mallinckrodt Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Mallinckrodt Main Business Overview
  13.1.5 Mallinckrodt Latest Developments
13.2 Santair AE
  13.2.1 Santair AE Company Information
  13.2.2 Santair AE Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.2.3 Santair AE Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Santair AE Main Business Overview
  13.2.5 Santair AE Latest Developments
13.3 VERO Biotech
  13.3.1 VERO Biotech Company Information
  13.3.2 VERO Biotech Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.3.3 VERO Biotech Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 VERO Biotech Main Business Overview
  13.3.5 VERO Biotech Latest Developments
13.4 Linde plc
  13.4.1 Linde plc Company Information
  13.4.2 Linde plc Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.4.3 Linde plc Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Linde plc Main Business Overview
  13.4.5 Linde plc Latest Developments
13.5 Beyond Air, Inc.
  13.5.1 Beyond Air, Inc. Company Information
  13.5.2 Beyond Air, Inc. Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.5.3 Beyond Air, Inc. Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Beyond Air, Inc. Main Business Overview
  13.5.5 Beyond Air, Inc. Latest Developments
13.6 SLE
  13.6.1 SLE Company Information
  13.6.2 SLE Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.6.3 SLE Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 SLE Main Business Overview
  13.6.5 SLE Latest Developments
13.7 Bellerophon Therapeutics
  13.7.1 Bellerophon Therapeutics Company Information
  13.7.2 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.7.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Bellerophon Therapeutics Main Business Overview
  13.7.5 Bellerophon Therapeutics Latest Developments
13.8 Air Liquide Healthcare
  13.8.1 Air Liquide Healthcare Company Information
  13.8.2 Air Liquide Healthcare Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.8.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Air Liquide Healthcare Main Business Overview
  13.8.5 Air Liquide Healthcare Latest Developments
13.9 International Biomedical
  13.9.1 International Biomedical Company Information
  13.9.2 International Biomedical Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.9.3 International Biomedical Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 International Biomedical Main Business Overview
  13.9.5 International Biomedical Latest Developments
13.10 Circassia Pharmaceuticals
  13.10.1 Circassia Pharmaceuticals Company Information
  13.10.2 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
  13.10.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Circassia Pharmaceuticals Main Business Overview
  13.10.5 Circassia Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Inhaled Nitric Oxide Delivery System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Inhaled Nitric Oxide Delivery System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pediatric
Table 4. Major Players of Adult
Table 5. Global Inhaled Nitric Oxide Delivery System Sales by Type (2021-2026) & (K Units)
Table 6. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Type (2021-2026)
Table 7. Global Inhaled Nitric Oxide Delivery System Revenue by Type (2021-2026) & ($ million)
Table 8. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Type (2021-2026)
Table 9. Global Inhaled Nitric Oxide Delivery System Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Inhaled Nitric Oxide Delivery System Sale by Application (2021-2026) & (K Units)
Table 11. Global Inhaled Nitric Oxide Delivery System Sale Market Share by Application (2021-2026)
Table 12. Global Inhaled Nitric Oxide Delivery System Revenue by Application (2021-2026) & ($ million)
Table 13. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Application (2021-2026)
Table 14. Global Inhaled Nitric Oxide Delivery System Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Inhaled Nitric Oxide Delivery System Sales by Company (2021-2026) & (K Units)
Table 16. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Company (2021-2026)
Table 17. Global Inhaled Nitric Oxide Delivery System Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Company (2021-2026)
Table 19. Global Inhaled Nitric Oxide Delivery System Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Inhaled Nitric Oxide Delivery System Producing Area Distribution and Sales Area
Table 21. Players Inhaled Nitric Oxide Delivery System Products Offered
Table 22. Inhaled Nitric Oxide Delivery System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Inhaled Nitric Oxide Delivery System Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Inhaled Nitric Oxide Delivery System Sales Market Share Geographic Region (2021-2026)
Table 27. Global Inhaled Nitric Oxide Delivery System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Inhaled Nitric Oxide Delivery System Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Country/Region (2021-2026)
Table 31. Global Inhaled Nitric Oxide Delivery System Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Inhaled Nitric Oxide Delivery System Sales by Country (2021-2026) & (K Units)
Table 34. Americas Inhaled Nitric Oxide Delivery System Sales Market Share by Country (2021-2026)
Table 35. Americas Inhaled Nitric Oxide Delivery System Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Inhaled Nitric Oxide Delivery System Sales by Type (2021-2026) & (K Units)
Table 37. Americas Inhaled Nitric Oxide Delivery System Sales by Application (2021-2026) & (K Units)
Table 38. APAC Inhaled Nitric Oxide Delivery System Sales by Region (2021-2026) & (K Units)
Table 39. APAC Inhaled Nitric Oxide Delivery System Sales Market Share by Region (2021-2026)
Table 40. APAC Inhaled Nitric Oxide Delivery System Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Inhaled Nitric Oxide Delivery System Sales by Type (2021-2026) & (K Units)
Table 42. APAC Inhaled Nitric Oxide Delivery System Sales by Application (2021-2026) & (K Units)
Table 43. Europe Inhaled Nitric Oxide Delivery System Sales by Country (2021-2026) & (K Units)
Table 44. Europe Inhaled Nitric Oxide Delivery System Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Inhaled Nitric Oxide Delivery System Sales by Type (2021-2026) & (K Units)
Table 46. Europe Inhaled Nitric Oxide Delivery System Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Inhaled Nitric Oxide Delivery System Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Inhaled Nitric Oxide Delivery System Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Inhaled Nitric Oxide Delivery System Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Inhaled Nitric Oxide Delivery System Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Inhaled Nitric Oxide Delivery System
Table 52. Key Market Challenges & Risks of Inhaled Nitric Oxide Delivery System
Table 53. Key Industry Trends of Inhaled Nitric Oxide Delivery System
Table 54. Inhaled Nitric Oxide Delivery System Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Inhaled Nitric Oxide Delivery System Distributors List
Table 57. Inhaled Nitric Oxide Delivery System Customer List
Table 58. Global Inhaled Nitric Oxide Delivery System Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Inhaled Nitric Oxide Delivery System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Inhaled Nitric Oxide Delivery System Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Inhaled Nitric Oxide Delivery System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Inhaled Nitric Oxide Delivery System Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Inhaled Nitric Oxide Delivery System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Inhaled Nitric Oxide Delivery System Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Inhaled Nitric Oxide Delivery System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Inhaled Nitric Oxide Delivery System Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Inhaled Nitric Oxide Delivery System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Inhaled Nitric Oxide Delivery System Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Inhaled Nitric Oxide Delivery System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Inhaled Nitric Oxide Delivery System Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Inhaled Nitric Oxide Delivery System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Mallinckrodt Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 73. Mallinckrodt Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 74. Mallinckrodt Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Mallinckrodt Main Business
Table 76. Mallinckrodt Latest Developments
Table 77. Santair AE Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 78. Santair AE Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 79. Santair AE Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Santair AE Main Business
Table 81. Santair AE Latest Developments
Table 82. VERO Biotech Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 83. VERO Biotech Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 84. VERO Biotech Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. VERO Biotech Main Business
Table 86. VERO Biotech Latest Developments
Table 87. Linde plc Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 88. Linde plc Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 89. Linde plc Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Linde plc Main Business
Table 91. Linde plc Latest Developments
Table 92. Beyond Air, Inc. Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 93. Beyond Air, Inc. Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 94. Beyond Air, Inc. Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Beyond Air, Inc. Main Business
Table 96. Beyond Air, Inc. Latest Developments
Table 97. SLE Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 98. SLE Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 99. SLE Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. SLE Main Business
Table 101. SLE Latest Developments
Table 102. Bellerophon Therapeutics Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 103. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 104. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Bellerophon Therapeutics Main Business
Table 106. Bellerophon Therapeutics Latest Developments
Table 107. Air Liquide Healthcare Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 108. Air Liquide Healthcare Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 109. Air Liquide Healthcare Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Air Liquide Healthcare Main Business
Table 111. Air Liquide Healthcare Latest Developments
Table 112. International Biomedical Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 113. International Biomedical Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 114. International Biomedical Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. International Biomedical Main Business
Table 116. International Biomedical Latest Developments
Table 117. Circassia Pharmaceuticals Basic Information, Inhaled Nitric Oxide Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 118. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery System Product Portfolios and Specifications
Table 119. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Circassia Pharmaceuticals Main Business
Table 121. Circassia Pharmaceuticals Latest Developments

LIST OF FIGURES

Figure 1. Picture of Inhaled Nitric Oxide Delivery System
Figure 2. Inhaled Nitric Oxide Delivery System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhaled Nitric Oxide Delivery System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Inhaled Nitric Oxide Delivery System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Inhaled Nitric Oxide Delivery System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Inhaled Nitric Oxide Delivery System Sales Market Share by Country/Region (2025)
Figure 10. Inhaled Nitric Oxide Delivery System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Pediatric
Figure 12. Product Picture of Adult
Figure 13. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Type in 2026
Figure 14. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Type (2021-2026)
Figure 15. Inhaled Nitric Oxide Delivery System Consumed in Hospitals
Figure 16. Global Inhaled Nitric Oxide Delivery System Market: Hospitals (2021-2026) & (K Units)
Figure 17. Inhaled Nitric Oxide Delivery System Consumed in Ambulatory Surgical Centers
Figure 18. Global Inhaled Nitric Oxide Delivery System Market: Ambulatory Surgical Centers (2021-2026) & (K Units)
Figure 19. Inhaled Nitric Oxide Delivery System Consumed in Others
Figure 20. Global Inhaled Nitric Oxide Delivery System Market: Others (2021-2026) & (K Units)
Figure 21. Global Inhaled Nitric Oxide Delivery System Sale Market Share by Application (2025)
Figure 22. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Application in 2026
Figure 23. Inhaled Nitric Oxide Delivery System Sales by Company in 2026 (K Units)
Figure 24. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Company in 2026
Figure 25. Inhaled Nitric Oxide Delivery System Revenue by Company in 2026 ($ millions)
Figure 26. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Company in 2026
Figure 27. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Inhaled Nitric Oxide Delivery System Sales 2021-2026 (K Units)
Figure 30. Americas Inhaled Nitric Oxide Delivery System Revenue 2021-2026 ($ millions)
Figure 31. APAC Inhaled Nitric Oxide Delivery System Sales 2021-2026 (K Units)
Figure 32. APAC Inhaled Nitric Oxide Delivery System Revenue 2021-2026 ($ millions)
Figure 33. Europe Inhaled Nitric Oxide Delivery System Sales 2021-2026 (K Units)
Figure 34. Europe Inhaled Nitric Oxide Delivery System Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Inhaled Nitric Oxide Delivery System Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Inhaled Nitric Oxide Delivery System Revenue 2021-2026 ($ millions)
Figure 37. Americas Inhaled Nitric Oxide Delivery System Sales Market Share by Country in 2026
Figure 38. Americas Inhaled Nitric Oxide Delivery System Revenue Market Share by Country (2021-2026)
Figure 39. Americas Inhaled Nitric Oxide Delivery System Sales Market Share by Type (2021-2026)
Figure 40. Americas Inhaled Nitric Oxide Delivery System Sales Market Share by Application (2021-2026)
Figure 41. United States Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Inhaled Nitric Oxide Delivery System Sales Market Share by Region in 2026
Figure 46. APAC Inhaled Nitric Oxide Delivery System Revenue Market Share by Region (2021-2026)
Figure 47. APAC Inhaled Nitric Oxide Delivery System Sales Market Share by Type (2021-2026)
Figure 48. APAC Inhaled Nitric Oxide Delivery System Sales Market Share by Application (2021-2026)
Figure 49. China Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 53. India Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Inhaled Nitric Oxide Delivery System Sales Market Share by Country in 2026
Figure 57. Europe Inhaled Nitric Oxide Delivery System Revenue Market Share by Country (2021-2026)
Figure 58. Europe Inhaled Nitric Oxide Delivery System Sales Market Share by Type (2021-2026)
Figure 59. Europe Inhaled Nitric Oxide Delivery System Sales Market Share by Application (2021-2026)
Figure 60. Germany Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 61. France Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Inhaled Nitric Oxide Delivery System Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Inhaled Nitric Oxide Delivery System Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Inhaled Nitric Oxide Delivery System Sales Market Share by Application (2021-2026)
Figure 68. Egypt Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Inhaled Nitric Oxide Delivery System Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Inhaled Nitric Oxide Delivery System in 2026
Figure 74. Manufacturing Process Analysis of Inhaled Nitric Oxide Delivery System
Figure 75. Industry Chain Structure of Inhaled Nitric Oxide Delivery System
Figure 76. Channels of Distribution
Figure 77. Global Inhaled Nitric Oxide Delivery System Sales Market Forecast by Region (2027-2032)
Figure 78. Global Inhaled Nitric Oxide Delivery System Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Inhaled Nitric Oxide Delivery System Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Inhaled Nitric Oxide Delivery System Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Inhaled Nitric Oxide Delivery System Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Inhaled Nitric Oxide Delivery System Revenue Market Share Forecast by Application (2027-2032)